Related Experiment Video
Updated: May 17, 2026
11:28
A Reference Broth Microdilution Method for Dalbavancin In Vitro Susceptibility Testing of Bacteria that Grow Aerobically
Published on: September 9, 2015
BSAC standardized disc susceptibility testing method (version 11)
1NPHS Microbiology Cardiff, University Hospital of Wales, Heath Park, Cardiff CF14 4XW, UK. robin.howe@wales.nhs.uk
The Journal of Antimicrobial Chemotherapy
|October 26, 2012
Summary
Version 11 of the British Society for Antimicrobial Chemotherapy (BSAC) disc susceptibility testing method includes updated interpretive criteria. These changes enhance the reliability and clinical use of antimicrobial susceptibility testing guidance.
Area of Science:
- Clinical microbiology
- Antimicrobial resistance
Background:
- The British Society for Antimicrobial Chemotherapy (BSAC) provides standardized guidelines for antimicrobial susceptibility testing.
- Accurate susceptibility testing is crucial for guiding antibiotic therapy and combating antimicrobial resistance.
Purpose of the Study:
- To outline the key amendments in version 11 of the BSAC standardized disc susceptibility testing method.
- To explain the rationale behind the updated interpretive criteria, focusing on harmonization with EUCAST MIC breakpoints.
Main Methods:
- The article reviews amendments to the BSAC standardized disc susceptibility testing method, version 11.
- It details changes in interpretive criteria for specific organism/drug combinations.
Main Results:
- The core disc susceptibility testing methodology remains consistent.
- Updated interpretive criteria have been introduced for certain organism/drug combinations.
Conclusions:
- Version 11 of the BSAC guidelines incorporates crucial updates to interpretive criteria.
- These revisions aim to improve the clinical applicability and reliability of antimicrobial susceptibility testing.
